Patent · US Active

Chemoembolization composition comprising anti-angiogenic agents

US9724421B2 · kind B2 · utility

2Cited by

0References

24Claims

0Family size

Assignee

CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (C.H.U.V.) · CH

Inventors

Alban Denys · Lausanne, CH
Pierre Bize · Cheseaux, CH
Olivier Jordan · Prangins, CH
Eric Doelker · Veyrier, CH
Nathalie Boulens · Confignon, CH

Key dates

Filing date	Nov 29, 2011
Grant date	Aug 8, 2017
Priority date	—
Expiry date	May 18, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to chemoembolization composition for anti-angiogenic agent delivery. The invention further relates to a method of preparing chemoembolization composition and to the use of chemoembolization composition in the method for treating solid tumor cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.